Gregory J. Mossinghoff
Founder at Tavros Therapeutics, Inc.
Profile
Gregory J.
Mossinghoff was the founder of Integrated Oncology Solutions, Inc. (founded in 2006) and Novolipid, Inc. (founded in 2010) where he held the titles of President & Chief Executive Officer.
He is also the founder of Tavros Therapeutics, Inc. Mr. Mossinghoff's former jobs include President, Chief Business Officer & Director at Inspire Pharmaceuticals, Inc. (1998-2005), Executive Vice President & Chief Business Officer at Zoion Pharma, Inc. (2010-2015), and Secretary & Chief Business Officer at G1 Therapeutics, Inc. (2015-2018).
Mr. Mossinghoff received his undergraduate degree from the University of Virginia and his MBA from George Mason University.
Gregory J. Mossinghoff active positions
Companies | Position | Start |
---|---|---|
Tavros Therapeutics, Inc.
Tavros Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tavros Therapeutics, Inc. operates as a biotechnology company. It develops novel therapies for cancer. The company was founded in 2019 and is headquartered in Durham, NC. | Founder | - |
Former positions of Gregory J. Mossinghoff
Companies | Position | End |
---|---|---|
G1 THERAPEUTICS, INC. | Corporate Officer/Principal | 2017-12-31 |
Zoion Pharma, Inc.
Zoion Pharma, Inc. Pharmaceuticals: MajorHealth Technology Zoion Pharma, Inc. develops drugs for veterinary disorders. The private company is based in Stamford. | Corporate Officer/Principal | 2014-12-31 |
Novolipid, Inc.
Novolipid, Inc. Pharmaceuticals: MajorHealth Technology Novolipid, Inc. develops oncology drug products. The private company is based in Durham. The American company was founded by Gregory J. Mossinghoff. | Chief Executive Officer | 2012-12-31 |
Integrated Oncology Solutions, Inc. | Chief Executive Officer | 2009-12-31 |
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | President | 2004-12-31 |
Training of Gregory J. Mossinghoff
University of Virginia | Undergraduate Degree |
George Mason University | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
G1 THERAPEUTICS, INC. | Health Technology |
Private companies | 5 |
---|---|
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Health Technology |
Integrated Oncology Solutions, Inc. | |
Zoion Pharma, Inc.
Zoion Pharma, Inc. Pharmaceuticals: MajorHealth Technology Zoion Pharma, Inc. develops drugs for veterinary disorders. The private company is based in Stamford. | Health Technology |
Novolipid, Inc.
Novolipid, Inc. Pharmaceuticals: MajorHealth Technology Novolipid, Inc. develops oncology drug products. The private company is based in Durham. The American company was founded by Gregory J. Mossinghoff. | Health Technology |
Tavros Therapeutics, Inc.
Tavros Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tavros Therapeutics, Inc. operates as a biotechnology company. It develops novel therapies for cancer. The company was founded in 2019 and is headquartered in Durham, NC. | Commercial Services |
- Stock Market
- Insiders
- Gregory J. Mossinghoff